Akebia Therapeutics
AKBA
$2.74
Share price
-1.54%
Change (1 day)
1.01%
Change (1 year)
Categories
Akebia Therapeutics (AKBA) - Cash on Hand
Cash on Hand as of December 2024 : C$74.11 Million
According to Akebia Therapeutics's latest financial reports the company has C$74.11 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Akebia Therapeutics - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | C$74.43 M | 30.74% |
| 2023-12-31 | C$56.93 M | -53.62% |
| 2022-12-31 | C$0.12 B | -35.7% |
| 2021-12-31 | C$0.19 B | -44.28% |
| 2020-12-31 | C$0.34 B | 77.61% |
| 2019-12-31 | C$0.19 B | -55.97% |
| 2018-12-31 | C$0.43 B | 9.66% |
| 2017-12-31 | C$0.39 B | 14.2% |
| 2016-12-31 | C$0.34 B | 82.16% |
| 2015-12-31 | C$0.19 B | 51.95% |
| 2014-12-31 | C$0.12 B | 264.72% |
| 2013-12-31 | C$34.65 M | 2023.72% |
| 2012-12-31 | C$1.63 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | C$17.10 B | 22,982.71% | 🇺🇸 USA |
 | C$19.07 B | 25,639.35% | 🇨🇭 Switzerland |
 | C$35.04 B | 47,175.88% | 🇺🇸 USA |
 | C$0.36 B | 392.05% | 🇺🇸 USA |